De Novo device
AQUABEAM Robotic System
Procept Biorobotics · Fluid Jet Removal System (PZP, Class II) · First FDA decision Dec 21, 2017, newest Jun 23, 2026Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
De Novo pathway
Device trials
12
Naming "AQUABEAM"
MAUDE reports
1,285
Brand "AQUABEAM", since 2015
PubMed studies
40
Mentioning "AQUABEAM"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AQUABEAM Robotic System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- AQUABEAM Robotic System510(k)
K253211 · Decided Jun 23, 2026 · 267 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
K241952 · Decided Sep 30, 2024 · 89 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
- AquaBeam Robotic System510(k)
K231024 · Decided Aug 30, 2023 · 141 days after receipt
Device type: Fluid Jet Removal System (PZP) · General & Plastic Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AQUABEAM", any status and sponsor, newest update first.
- WATER IV PCa (AS Sub-study)Pivotal-lookingRecruiting
PROCEPT BioRoboticsPublic (PRCT)
NCT07650448 · 333 participants (planned) · Start Sep 11, 2026 · Primary completion Dec 2028
Device: Aquablation Therapy · For: Localized Prostate Cancer
Sites: Chandler, Arizona; Los Angeles, California; Murrieta, California · 28 sites in all
- WATER IV Prostate CancerPivotal-lookingActive, not recruiting
PROCEPT BioRoboticsPublic (PRCT)
NCT06651632 · 280 participants (planned) · Start Feb 3, 2025 · Primary completion Jul 2027
Device: Aquablation Therapy · For: Localized Prostate Cancer
Sites: Chandler, Arizona; Mesa, Arizona; Los Angeles, California · 37 sites in all
- PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTsActive, not recruiting
PROCEPT BioRoboticsPublic (PRCT)
NCT06051942 · 125 participants · Start Nov 22, 2022 · Primary completion Jul 2026
Device: Robotic Waterjet Treatment · For: Benign Prostatic Hyperplasia; Localized Prostate Cancer
Sites: La Mesa, California; Glenview, Illinois; Alexandria, Virginia · 6 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AQUABEAM", and for the whole product code for context.
This brand
1,285 reports: 585 malfunction, 672 injury, 28 death
Whole product code PZP
1,507 reports: 686 malfunction, 781 injury, 37 death
Newest reports for this brand
- AQUABEAM Robotic SystemInjury
PROCEPT BioRobotics Corporation
3012977056-2026-00216 · Received Oct 20, 2026 · Event dated Oct 7, 2026
Device type: Fluid Jet Removal System (PZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
- AQUABEAM Robotic SystemInjury
PROCEPT BioRobotics Corporation
3012977056-2026-00213 · Received Oct 19, 2026 · Event dated Sep 24, 2026
Device type: Fluid Jet Removal System (PZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Perforation
- AQUABEAM Robotic SystemMalfunction
PROCEPT BioRobotics Corporation
3012977056-2026-00212 · Received Oct 19, 2026 · Event dated Oct 12, 2026
Device type: Fluid Jet Removal System (PZP)
Device problem as coded: Visual Prompts will not Clear
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- AQUABEAM Handpiece, REF: HP2000, a sterile single-use component of the AQUABEAM Robotic System.Open, Classified
PROCEPT BIOROBOTICS CORPORATION
Z-2330-2021 · Started Jul 9, 2021
Reason given: Scope tube tip may detach from the telescoping tube, which is attached to a single-use handpiece, a component of an aquablation robotic system. Both tip detachment and entire tip separation form the handpiece may lead to procedural delay for handpiece exchange. Tip detachment can be seen cystoscopically and tip...
Cause as FDA categorized it: Component change control · Device type: Fluid Jet Removal System (PZP)
Published research
The most relevant PubMed records for "AQUABEAM"[tiab]. The summary above synthesizes these.
- What's New in Aquablation.
Lee R, Roehrborn C · Eur Urol Focus · 2018Review
- Robots to Improve Surgery for All.
Mertz L · IEEE Pulse · 2022
- [Aquablation Treatment for Benign Prostatic Obstruction].
Bach T, Mahler D · Ther Umsch · 2023English Abstract
- [Minimally-Invasive Surgical Techniques (MIST): Shedding Light on the Mist].
Netsch C, Gross AJ, Herrmann TR, et al. · Aktuelle Urol · 2024Review
- Aquablation/AquaBeam Waterjet Therapy for Benign Prostatic Hyperplasia: Three-Year Functional and Ejaculatory Outcomes in a Multicenter Real-World Italian Cohort.
Porreca A, D'Agostino D, De Marchi D, et al. · Low Urin Tract Symptoms · 2026Multicenter Study
- Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review.
He W, Ding T, Niu Z, et al. · Front Endocrinol (Lausanne) · 2023Meta-Analysis, Systematic Review
- Update on minimally invasive surgery and benign prostatic hyperplasia.
Chung ASJ, Woo HH · Asian J Urol · 2018Review
- [The future of laparoscopy and robotics in urology].
Rassweiler J, Goezen AS, Klein JT, et al. · Aktuelle Urol · 2018Review
- Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
Gilling P, Reuther R, Kahokehr A, et al. · BJU Int · 2016Clinical Trial, Research Support, Non-U.S. Gov't
- Transfusion rates after 800 Aquablation procedures using various haemostasis methods.
Elterman D, Bach T, Rijo E, et al. · BJU Int · 2020Multicenter Study, Research Support, Non-U.S. Gov't
- [Minimally invasive treatment of benign prostatic hyperplasia].
Magistro G, Stief CG, Gratzke C · Urologe A · 2016Review
- [Novel minimally invasive treatment options for male lower urinary tract symptom].
Magistro G, Stief CG, Gratzke C · Urologe A · 2019Review
Other devices of this type
Also filed under product code PZP.
- HYDROS Robotic System (HY1000)Procept Biorobotics · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.